CIBC Innovation Banking announced today that it has provided a $7.5M facility in growth capital to SmartSkin Technologies, Inc. (SmartSkin), based in Atlantic Canada. The company will use the financing to expand its market reach.
SmartSkin delivers manufacturing intelligence solutions that empower pharmaceutical and beverage producers to optimize efficiency, ensure quality, and eliminate costly production issues. Its technology uses pressure-sensitive sensors and AI-driven analytics to provide global manufacturers with actionable data on the forces their containers experience during the filling, packaging and transporting process.
“This financing fuels our ambition to become the essential intelligence layer for pharmaceutical and beverage manufacturing,” said Evan Justason, CEO, SmartSkin. “We’re no longer just solving individual problems—we’re building the digital foundation these industries will depend on to operate efficiently, safely, and with zero defects. With the trust of global leaders and a presence across every major market, SmartSkin is positioned to be not just a solution—but a standard. We’re grateful to the team at CIBC Innovation Banking for recognizing our vision and backing it with the kind of flexible, growth-oriented support that makes this next stage possible.”
“We are impressed by the flexibility of SmartSkin’s technology and its ability to proactively detect potential issues on production lines and precisely identify problems as they occur,” said Eric Laflamme, Managing Director, CIBC Innovation Banking. “We are proud to support the company in its growth journey.”
SmartSkin’s investors include the Business Development Bank of Canada, the New Brunswick Innovation Fund, East Valley and Schott Pharma.
Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!
